Literature DB >> 25634727

Endometrial Cancer: Hidden Pathology in a Patient with Abnormal Uterine Bleeding and Known Leiomyoma.

Trisha Sri1, Albert J Steren, Pamela Stratton.   

Abstract

Uterine leiomyomas and endometrial pathology are both associated with abnormal uterine bleeding. We report a case in which a nulliparous woman with heavy uterine bleeding and leiomyomas had undergone two prior hysteroscopic myomectomies for benign leiomyomas. She was evaluated, but was ineligible for a clinical trial of a novel Magnetic Resonance guided High Intensity Focused Ultrasound (MRgx200B;HIFU) device. The 8 cm, prolapsed submucosal leiomyoma hindered endometrial sampling and was inaccessible to HIFU treatment. Preoperatively, neither endometrial sampling nor saline sonohysterography was technically feasible. She underwent hysterectomy, and on histological examination of specimen, stage 1A grade 1 endometrial carcinoma was found on the endometrial side of the prolapsing fibroid. Endometrial pathology is an important consideration in the evaluation of abnormal uterine bleeding, even in women with large prolapsing leiomyoma.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25634727      PMCID: PMC4516716          DOI: 10.1159/000370002

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  7 in total

Review 1.  Endometrial cancer.

Authors:  Vivek Arora; Michael A Quinn
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-01-25       Impact factor: 5.237

2.  Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology.

Authors:  Aradhana M Venkatesan; Ari Partanen; Tajana Klepac Pulanic; Matthew R Dreher; John Fischer; Robert K Zurawin; Raja Muthupillai; Sham Sokka; Heikki J Nieminen; Ninet Sinaii; Maria Merino; Bradford J Wood; Pamela Stratton
Journal:  J Vasc Interv Radiol       Date:  2012-06       Impact factor: 3.464

3.  Gynecological conditions and the risk of endometrial cancer.

Authors:  Ingrid J Rowlands; Christina M Nagle; Amanda B Spurdle; Penelope M Webb
Journal:  Gynecol Oncol       Date:  2011-09-16       Impact factor: 5.482

Review 4.  Modern evaluation of the endometrium.

Authors:  Steven R Goldstein
Journal:  Obstet Gynecol       Date:  2010-07       Impact factor: 7.661

Review 5.  Uterine leiomyomas: individualizing the approach to a heterogeneous condition.

Authors:  Shannon K Laughlin; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

6.  Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage.

Authors:  Elizabeth Suh-Burgmann; Yun-Yi Hung; Mary Anne Armstrong
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

Review 7.  Endometrial cancer.

Authors:  Joel I Sorosky
Journal:  Obstet Gynecol       Date:  2008-02       Impact factor: 7.661

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.